Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Proteomic profiling by array of tyrosine kinase activity in metastatic malignant melanoma from human tissue specimens


ABSTRACT: Tyrosine kinase activity profiling of metatstatic malignant melanoma and normal skin tissue samples was performed using peptide kinase arrays. All samples were run in triplicates with and withouth inhbitor PLX4032 and Sutent Malate in order to identify how tyrosine kinases responds to kinase inhibitor treatment, ex vivo.

ORGANISM(S): Homo sapiens

DISEASE(S): normal

SUBMITTER: Andliena Tahiri 

PROVIDER: E-MTAB-1245 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma.

Tahiri Andliena A   Røe Kathrine K   Ree Anne H AH   de Wijn Rik R   Risberg Karianne K   Busch Christian C   Lønning Per E PE   Kristensen Vessela V   Geisler Jürgen J  

PloS one 20130830 8


<h4>Background</h4>Treatment of metastatic malignant melanoma patients harboring BRAF(V600E) has improved drastically after the discovery of the BRAF inhibitor, vemurafenib. However, drug resistance is a recurring problem, and prognoses are still very bad for patients harboring BRAF wild-type. Better markers for targeted therapy are therefore urgently needed.<h4>Methodology</h4>In this study, we assessed the individual kinase activity profiles in 26 tumor samples obtained from patients with meta  ...[more]

Similar Datasets

2010-08-05 | E-TABM-913 | biostudies-arrayexpress
2016-06-15 | E-MTAB-3870 | biostudies-arrayexpress
2017-12-15 | E-MTAB-4795 | biostudies-arrayexpress
2013-04-15 | E-MTAB-1572 | biostudies-arrayexpress
2020-07-07 | PXD012813 | Pride
2018-10-17 | PXD002133 | Pride
2020-11-18 | PXD020250 | Pride
2020-07-07 | PXD012812 | Pride
2023-07-20 | PXD038551 | Pride
2013-05-22 | E-MEXP-3374 | biostudies-arrayexpress